Heroin supply and health: new perspectives

The toxicology and characteristics of fatal new psychoactive stimulant and hallucinogen-related poisonings in Australia, 2000-2025.

Drug and alcohol dependence reports·2026

Changing characteristics in the 2020s of fatal 'novel' benzodiazepine toxicity cases in Australia.

Drug and alcohol dependence·2026

Trends in gamma-hydroxybutyrate use, harms and treatment in Australia, 2013 to 2024.

Addiction (Abingdon, England)·2026

Women using menopausal hormone therapy who suicide have multiple risk factors.

Maturitas·2025

Rates and Clinical Characteristics of Self-Administered Fatal Ketamine-Related Poisoning in Australia, 2000-2025.

Drug and alcohol review·2025

Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000-2025.

Addiction (Abingdon, England)·2025

Prescribed alternative stimulants among people who use unregulated stimulants: Examining the association between maximum dose reached and medication discontinuation in the first 3 years of implementation in British Columbia, Canada.

Addiction (Abingdon, England)·2026

Marketing features of derived intoxicating cannabinoid product brands on Instagram: A content analysis.

Addiction (Abingdon, England)·2026

From allostasis to addiction: Cortisol dysregulation, daily stress and relations with 9-year alcohol and substance use disorder severity in community adults.

Addiction (Abingdon, England)·2026

Joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in substance use disorder: Longitudinal evidence from the All of Us research program.

Addiction (Abingdon, England)·2026

Towards the implementation of cannabis-focused apps in early intervention services for psychosis: A qualitative investigation of patient and clinician perspectives.

Addiction (Abingdon, England)·2026

The (very) early evidence of oxycodone addiction liability.

Addiction (Abingdon, England)·2026

Dyadic interactions and injecting practices: Unpacking the role of interpersonal dynamics in drug injection partnerships.

Drug and alcohol dependence·2026

Instruments for assessing healthcare professionals' knowledge, attitudes and practices regarding deprescribing: a scoping review.

International journal of clinical pharmacy·2026

Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Medication Titration Practices in Hemodialysis Patients in the US.

medRxiv : the preprint server for health sciences·2026

Clinician Perspectives on Prescribing Restrictions and Opioid Pain Management in Australian Podiatric Practice: A Qualitative Study.

Journal of foot and ankle research·2026

Toward a Pharmacy-Led Value-Based Care Model for Buprenorphine Initiation and Management (PharmValue): Development of a Scalable Pharmacist-Led Collaborative Practice Agreement for Medications for Opioid Use Disorder.

Substance use & addiction journal·2026

Implementation of pharmaceutical pictograms in pharmacy practice: A systematic review.

Journal of the American Pharmacists Association : JAPhA·2026

Related Experiment Videos

Heroin supply and health: new perspectives

Related Concept Videos

The toxicology and characteristics of fatal new psychoactive stimulant and hallucinogen-related poisonings in Australia, 2000-2025.

Changing characteristics in the 2020s of fatal 'novel' benzodiazepine toxicity cases in Australia.

Trends in gamma-hydroxybutyrate use, harms and treatment in Australia, 2013 to 2024.

Women using menopausal hormone therapy who suicide have multiple risk factors.

Rates and Clinical Characteristics of Self-Administered Fatal Ketamine-Related Poisoning in Australia, 2000-2025.

Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000-2025.

Prescribed alternative stimulants among people who use unregulated stimulants: Examining the association between maximum dose reached and medication discontinuation in the first 3 years of implementation in British Columbia, Canada.

Marketing features of derived intoxicating cannabinoid product brands on Instagram: A content analysis.

From allostasis to addiction: Cortisol dysregulation, daily stress and relations with 9-year alcohol and substance use disorder severity in community adults.

Joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in substance use disorder: Longitudinal evidence from the All of Us research program.

Towards the implementation of cannabis-focused apps in early intervention services for psychosis: A qualitative investigation of patient and clinician perspectives.

The (very) early evidence of oxycodone addiction liability.

Dyadic interactions and injecting practices: Unpacking the role of interpersonal dynamics in drug injection partnerships.

Instruments for assessing healthcare professionals' knowledge, attitudes and practices regarding deprescribing: a scoping review.

Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Medication Titration Practices in Hemodialysis Patients in the US.

Clinician Perspectives on Prescribing Restrictions and Opioid Pain Management in Australian Podiatric Practice: A Qualitative Study.

Toward a Pharmacy-Led Value-Based Care Model for Buprenorphine Initiation and Management (PharmValue): Development of a Scalable Pharmacist-Led Collaborative Practice Agreement for Medications for Opioid Use Disorder.

Implementation of pharmaceutical pictograms in pharmacy practice: A systematic review.

Related Experiment Videos

Heroin supply and health: new perspectives

Related Concept Videos

Related Articles